Publications

Résultats 151 à 160 sur 560 Publications
Titre Auteurs
Chercheurs du CCNV* / Stagiaires du CCNV**
Année Revue
Reentrant liquid condensate phase of proteins is stabilized by hydrophobic and non-ionic interactions
Krainer G, Welsh TJ, Joseph JA, Espinosa JR, Wittmann S, de Csilléry E, Sridhar A, Toprakcioglu Z, Gudiškytė G, Czekalska MA, Arter WE, Guillén-Boixet J, Franzmann TM, Qamar S, George-Hyslop PS*, Hyman AA, Collepardo-Guevara R, Alberti S, Knowles TPJ. 2021 Nature Communications
Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
Therriault, J.**, Pascoal, T. A**., Lussier, F. Z., Tissot, C., Chamoun, M., Bezgin, G., Servaes S., Benedet A.L., Ashton N.J., Karikari T.K., Lantero-Rodriguez J., Kunach P., Wang Y-T., Fernandez-Arias J., Massarweh G., Vitali P., Soucy J-P., Saha-Chaudhuri P., Blennow, K., Zetterberg H., Gauthie S.*, & Rosa-Neto, P.* 2022 Nature Aging
The degree of frailty as a translational measure of health in aging
Howlett SE, Rutenberg AD, Rockwood K* 2021 Nature Aging
A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases
Brum, W. S., Cullen, N. C., Janelidze, S., Ashton, N. J., Zimmer, E. R., Therriault, J.**, Benedet, A. L., Rahmouni, N.**, Tissot, C.**, Stevenson, J., Servaes, S., Triana-Baltzer, G., Kolb, H. C., Palmqvist, S., Stomrud, E., Rosa-Neto, P.*, Blennow, K., & Hansson, O 2023 Nature aging
SMPD1 mutations, activity, and alpha-synuclein accumulation in Parkinson’s disease. Alcalay, R.N., Mallett, V., Vanderperre, B., Tavassoly, O., Dauvilliers, Y., Wu, R.Y.J., Ruskey, J.A., Leblond, C.S., Ambalavanan, A., Laurent, S.B., Spiegelman, D., Dionne-Laporte, A., Liong, C., Levy, O.A., Fahn, S., Waters, C., Kuo, S.H., Chung, W.K., Ford, B., Marder, K.S., Kang, U.J., Hassin-Baer, S., Greenbaum, L., Trempe, J.F., Wolf, P., Oliva, P., Zhang, X.K., Clark, L.N., Langlois, M., Dion, P.A., Fon, E.A.**, Dupre, N.**, Rouleau, G.A.**, Gan-Or, Z**. 2019 Movement Disorders.
Type 2 Diabetes as a Determinant of Parkinson’s Disease Risk and Progression
Chohan H, Senkevich K, Patel RK, Bestwick JP, Jacobs BM, Bandres Ciga S, Gan-Or Z*, Noyce AJ. 2021 Movement Disorders
Analysis of Heterozygous PRKN Variants and Copy-Number Variations in Parkinson’s Disease
Yu E, Rudakou U, Krohn L, Mufti K, Ruskey JA, Asayesh F, Estiar MA, Spiegelman D, Surface M, Fahn S, Waters CH, Greenbaum L, Espay AJ, Dauvilliers Y, Dupré N, Rouleau GA*, Hassin-Baer S, Fon EA*, Alcalay RN, Gan-Or Z* 2020 Movement Disorders
C9orf72 and ATXN2 repeat expansions coexist in a family with ataxia, dementia, and parkinsonism.
Zhang, M.**, Xi, Z., Misquitta, K., Sato, C., Moreno, D., Liang, Y., Slow, E., Rogaeva, E., & Tartaglia, M. C. 2017 Movement Disorders
Full sequencing and haplotype analysis of MAPT in Parkinson’s disease and rapid eye movement sleep behavior disorder Li, J., Ruskey, J.A., Arnulf, I., Dauvilliers, Y., Hu, M.T.M., Hogl, B., Leblond, C.S., Zhou, S., Ambalavanan, A., Ross, J.P., Bourassa, C.V., Spiegelman, D., Laurent, S.B., Stefani, A., Charley Monaca, C., Cochen De Cock, V., Boivin, M., Ferini-Strambi, L., Plazzi, G., Antelmi, E., Young, P., Heidbreder, A., Labbe, C., Ferman, T.J., Dion, P.A., Fan, D., Desautels, A., Gagnon, J.F., Dupre, N., Fon, E.A., Montplaisir, J.Y., Boeve, B.F., Postuma, R.B., Rouleau, G.A., Ross, O.A., & Gan-Or, Z. 2018 Movement Disorders
Profiling novel metabolic biomarkers for Parkinson’s disease using in‐depth metabolomic analysis Han, W., Sapkota, S., Camicioli, R., Dixon, R. A., & Li, L. 2017 Movement Disorders
Résultats 151 à 160 sur 560 Publications
Go back to top